Pieters R - Search Results

1

Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.

Stumpel DJ, Schneider P, Seslija L, Osaki H, Williams O, Pieters R, Stam RW. Stumpel DJ, et al. Among authors: pieters r. Leukemia. 2012 Apr;26(4):682-92. doi: 10.1038/leu.2011.278. Epub 2011 Oct 21. Leukemia. 2012. PMID: 22015773

2

Adenosine deaminase and purine nucleoside phosphorylase in childhood lymphoblastic leukemia: relation with differentiation stage, in vitro drug resistance and clinical prognosis.

Pieters R, Huismans DR, Loonen AH, Peters GJ, Hählen K, van der Does-van den Berg A, van Wering ER, Veerman AJ. Pieters R, et al. Leukemia. 1992 May;6(5):375-80. Leukemia. 1992. PMID: 1593902

3

Prognostic significance of acid alpha-naphthyl acetate esterase and acid phosphatase in childhood acute lymphoblastic leukemia.

Pieters R, Veerman AJ. Pieters R, et al. Leuk Res. 1987;11(11):995-9. doi: 10.1016/0145-2126(87)90118-4. Leuk Res. 1987. PMID: 3480402

4

In vitro chemosensitivity assessed with the MTT assay in childhood acute non-lymphoblastic leukemia.

Klumper E, Pieters R, Kaspers GJ, Huismans DR, Loonen AH, Rottier MM, van Wering ER, van der Does-van den Berg A, Hählen K, Creutzig U, et al. Klumper E, et al. Among authors: pieters r. Leukemia. 1995 Nov;9(11):1864-9. Leukemia. 1995. PMID: 7475276

5

Topoisomerase II alpha gene expression in childhood acute lymphoblastic leukemia.

Klumper E, Giaccone G, Pieters R, Broekema G, van Ark-Otte J, van Wering ER, Kaspers GJ, Veerman AJ. Klumper E, et al. Among authors: pieters r. Leukemia. 1995 Oct;9(10):1653-60. Leukemia. 1995. PMID: 7564505

6

Drug combination testing in acute lymphoblastic leukemia using the MTT assay.

Kaspers GJ, Veerman AJ, Pieters R, Van Zantwijk I, Hählen K, Van Wering ER. Kaspers GJ, et al. Among authors: pieters r. Leuk Res. 1995 Mar;19(3):175-81. doi: 10.1016/0145-2126(94)00126-u. Leuk Res. 1995. PMID: 7700079

7

Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: a preliminary report.

Kaspers GJ, Kardos G, Pieters R, Van Zantwijk CH, Klumper E, Hählen K, de Waal FC, van Wering ER, Veerman AJ. Kaspers GJ, et al. Among authors: pieters r. Leukemia. 1994 Jul;8(7):1224-9. Leukemia. 1994. PMID: 8035616

8

Glucocorticoid resistance in childhood leukemia.

Kaspers GJ, Pieters R, Klumper E, De Waal FC, Veerman AJ. Kaspers GJ, et al. Among authors: pieters r. Leuk Lymphoma. 1994 Apr;13(3-4):187-201. doi: 10.3109/10428199409056282. Leuk Lymphoma. 1994. PMID: 8049644 Review.

9

In vitro cytotoxicity of mitoxantrone, daunorubicin and doxorubicin in untreated childhood acute leukemia.

Kaspers GL, Veerman AJ, Pieters R, van Zantwijk I, Klumper E, Hählen K, de Waal FC, van Wering ER. Kaspers GL, et al. Among authors: pieters r. Leukemia. 1994 Jan;8(1):24-9. Leukemia. 1994. PMID: 8289494

10

Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia.

Pieters R, Kaspers GJ, van Wering ER, Huismans DR, Loonen AH, Hählen K, Veerman AJ. Pieters R, et al. Leukemia. 1993 Mar;7(3):392-7. Leukemia. 1993. PMID: 8445945

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,016 results

Search Page

Filters